Open the mobile version, with barcode scanning
Class II Ongoing

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridg…

Why: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Company
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT, United States
Reported
Jul 8, 2026
Recall started
Jun 12, 2026
Where sold
OH
Amount
560 bottles
Full product description
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45
Lots / codes affected
Lot 3244413; Exp. 12/31/2028

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.